Fortive Corporation (FTV) has officially completed the spin-off of its Precision Technologies segment, forming a new independent company, Ralliant Corporation. The separation was finalized on June 28, 2025, and Ralliant began trading on the New York Stock Exchange under the ticker symbol "RAL", from June 30. Fortive will continue to trade under "FTV." On Sept. 4, 2024, Fortive announced plans to separate its Precision Technologies business into an independent publicly traded company, Ralliant. This will cre ...

On June 25, 2025, Ralliant Corp. RALW, a spin-off of Fortive Corp FTVW FTV commenced when-issued trading on the NYSE. Earlier on September 4, 2024, FTV announced plans to separate its Precision Technologies business into a separate publicly listed company, Ralliant Corp, via a tax-free spin-off transaction. The parent will retain the Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS) business segments, boasting a portfolio with 50% recurring revenue. We see the spin-off as a move ...

ATHENS, Greece, June 04, 2025 (GLOBE NEWSWIRE) -- TOP Ships Inc. (the "Company" or "TOP Ships") (NYSE American: TOPS), an international owner and operator of modern, fuel-efficient "ECO" tanker vessels, announced today that it intends to effect a spin-off of two of its Suezmax tanker vessels. Rubico Inc. ("Rubico"), currently a subsidiary of TOP Ships, would become an independent publicly-traded company listed on the Nasdaq Capital Market as a result of the planned spin-off. The initial assets of Rubico wil ...

Core Viewpoint - Vivani Medical, Inc. plans to spin off its subsidiary Cortigent, Inc. into an independent publicly traded company on Nasdaq by the third quarter of 2025, aiming to enhance value for both Vivani and Cortigent stockholders [1][3][6] Company Developments - Cortigent is developing the Orion Visual Cortical Prosthesis System to provide visual perception for the blind and a Stroke Recovery System to aid recovery of arm and hand movement post-stroke [1][8] - The Orion system has received FDA Breakthrough Device designation and completed a six-year Early Feasibility Study with promising results [2][8] - Cortigent's previous product, the Argus II, was the first FDA-authorized artificial vision device, successfully implanted in hundreds of patients [2][8] Strategic Focus - The spin-off will allow Vivani to concentrate on its proprietary NanoPortal drug implant technology, specifically for chronic weight management and type 2 diabetes [1][2][3] - Vivani's lead program includes a six-month subdermal GLP-1 implant for chronic weight management, with additional products in development for type 2 diabetes [9][11] Financial and Operational Structure - The spin-off is expected to provide clearer visibility into the financial and operational structures of both companies, enhancing understanding of their respective strategies and risks [5][10] - The transaction is subject to various conditions, including board approval and SEC and Nasdaq compliance [6] Management and Leadership - Cortigent's CEO, Jonathan Adams, has extensive experience in the biopharmaceutical field and aims to accelerate the development of Cortigent's technologies post-spin-off [2][8]

Shares of Sony Group (SONY 3.94%) rose on Tuesday. The company's stock was up 4% by the time the market closed. The move up comes as the S&P 500 jumped 2% and the Nasdaq Composite jumped 2.4%.Reuters reported that Sony will distribute 80% of newly created shares from the upcoming spin-off of its financial services arm. More details will be revealed in the company's Investor Day on Thursday.Shareholders will benefitSony took full control of Sony Financial Services several years ago, but after a change in Jap ...

Group 1 - The core viewpoint is that Medtronic's decision to spin off its diabetes business is expected to act as a near-term catalyst for its stock price [1] - A 'Buy' rating was assigned to Medtronic in March 2025, emphasizing the strength in its cardiac ablation solutions [1] - The company has a beneficial long position in its shares, indicating confidence in its future performance [1]

在资本市场的广阔天地中，分拆上市作为一种重要的资本运作方式，正日益受到企业和投资者的关注。它不仅为企业提供了新的 发展机遇，也为投资者带来了更多的投资选择。今天，利多星就带大家深入了解一下分拆上市。 分拆上市是指一家母公司（通常为上市公司）将其部分业务或资产剥离出来，单独成立一家新的子公司，然后将子公司在证券市 场上公开上市的过程。其核心是通过资产分割和股权重组，使子公司成为独立的上市主体，实现业务聚焦和价值重估。 二、分拆上市的主要形式 不同市场的上市规则差异较大，以下为中国证监会对境内分拆上市的核心要求（简化版）： 母公司资质- 上市满 3 年；- 最近 3 年连续盈利；- 对子公司持股比例不低于 50%（分拆后）。 子公司资质- 业务独立，与母公司不存在同业竞争；- 资产、财务、人员独立，内控健全。 财务指标- 子公司最近 1 年净利润占母公司比重不超过 50%；- 资产占比不超过 30%。 这些条件旨在确保分拆上市的企业具备良好的基本面和规范的运作，保护投资者的合法权益。 （一）境内分拆上市 母公司将子公司分拆后，在境内证券交易所（如 A 股主板、科创板、创业板等）上市。例如，2023 年，某科技集团 ...

The following is an extract from the “Iveco Group 2025 First Quarter Results” press release. The complete press release can be accessed by visiting the media section of the Iveco Group corporate website: https://www.ivecogroup.com/media/corporate_press_releases or consulting the accompanying PDF: The Company responded decisively to market downturn and laid strong foundationsfor future growth. Full year guidance confirmed in its entirety The Board has decided to proceed with the separation of the Defence bus ...

The Middleby Corporation (MIDD) reported first-quarter 2025 adjusted earnings of $2.08 per share, which beat the Zacks Consensus Estimate of $1.94. The bottom line increased 10.1% year over year due to lower costs.Net revenues of $906.6 million missed the consensus estimate of $941 million. The top line decreased 2.2% year over year. Organic sales decreased 3.8%. Acquired assets increased sales by 2.4%, while movements in foreign currencies had a negative impact of 0.8%. (Find the latest EPS estimates and s ...

MONACO , May 07, 2025 (GLOBE NEWSWIRE) -- Costamare Inc. (NYSE:CMRE) (the “Company”) announced today that it has completed the spin-off of its dry bulk business into a standalone public company, Costamare Bulkers Holdings Limited (“Costamare Bulkers”). Each holder of Costamare Inc. common shares received one common share of Costamare Bulkers Holdings Limited for every five Costamare Inc. common shares held as of the close of business on April 29, 2025. The successful execution of the Costamare Bulkers spin- ...